Volume 26, Number 7—July 2020
Dispatch
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
Wannarat A. Pongpirul, Joshua A. Mott, Joseph V. Woodring
, Timothy M. Uyeki, John R. MacArthur, Apichart Vachiraphan, Pawita Suwanvattana, Sumonmal Uttayamakul, Supamit Chunsuttiwat, Tawee Chotpitayasunondh, Krit Pongpirul, and Wisit Prasithsirikul
, Timothy M. Uyeki, John R. MacArthur, Apichart Vachiraphan, Pawita Suwanvattana, Sumonmal Uttayamakul, Supamit Chunsuttiwat, Tawee Chotpitayasunondh, Krit Pongpirul, and Wisit Prasithsirikul
Table 2
Clinical illness history and calculated intervals of confirmed COVID-19 patients in Bamrasnaradura Infectious Diseases Institute, Bangkok, Thailand, 2020*
| Patient no. |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4† | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||||
| Onset of symptoms | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NA | NA | NA |
| Onset of fever | 2 | 0 | 0 | NA | 0 | 0 | 9 | 0 | 1 | 0 | 0 | 0 (0–1.25) | 1.2 (2.8) | – |
| First medical visit | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 3 | 2 | 3 (2–4) | 3.6 (3.3) | – |
| Admitted to BIDI | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 8 | 5 | 4 (2–5) | 4.4 (3.5) | – |
| SARS-CoV-2 RNA detected | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 8 | 5 | 4 (2–5) | 4.4 (3.5) | – |
| Fever resolution | 4 | 3 | 6 | NA | 6 | 4 | 13 | 4 | 6 | 13 | 11 | 6 (4–11.5) | 7.0 (3.9) | – |
| Clinical resolution | 13 | 10 | 11 | NA | 9 | 9 | 17 | 15 | 9 | 13 | 13 | 12 (9–13.5) | 11.9 (2.8) | – |
| SARS-CoV-2 RNA undetectable | 14 | 10 | 13 | 4 | 9 | 26 | 24 | 29 | 9 | 14 | 30 | 14 (9–26) | 16.5 (9.1) | – |
| Discharge |
15 |
11 |
14 |
6 |
15 |
29 |
26 |
32 |
11 |
16 |
33 |
15 (11–29) |
18.9 (9.4) |
– |
| Calculated intervals | ||||||||||||||
| Admission to discharge | 11 | 9 | 10 | 6 | 12 | 25 | 13 | 30 | 8 | 8 | 28 | 11 (8–25) | 14.5 (8.7) | – |
| Fever resolution to SARS-COV-2 RNA undetectable | 10 | 7 | 7 | NA | 3 | 22 | 11 | 25 | 3 | 1 | 19 | 9 (3–19.75) | 10.8 (8.4) | – |
| Admission to fever resolution | 0 | 1 | 2 | NA | 3 | 0 | 0 | 2 | 3 | 5 | 6 | 2 (0–3.5) | 2.2 (2.1) | – |
| Fever resolution to clinical resolution | 9 | 7 | 5 | NA | 3 | 5 | 4 | 11 | 3 | 0 | 2 | 5 (3–7.5) | 4.9 (3.3) | – |
| Admission to clinical resolution | 9 | 8 | 7 | NA | 6 | 5 | 4 | 13 | 6 | 5 | 8 | 7 (5–8.25) | 7.1 (2.6) | – |
| Fever onset to fever resolution | 2 | 3 | 6 | NA | 6 | 4 | 4 | 4 | 5 | 13 | 11 | 5 (4–7.25) | 5.8 (3.5) | – |
| Admission to SARS-COV-2 RNA undetectable | 10 | 8 | 9 | 4 | 6 | 22 | 11 | 27 | 6 | 6 | 25 | 10 (6–22.75) | 12.2 (8.3) | – |
| Fever resolution to discharge |
11 |
8 |
8 |
NA |
9 |
25 |
13 |
28 |
5 |
3 |
22 |
10 (7–22.75) |
13.2 (8.7) |
– |
| Fever duration by stratified condition | ||||||||||||||
| Patients detected through airport screening | 2 | 3 | 6 | – | – | – | – | – | – | – | – | 3 (2–6) | 3.7 (2.1) | 0.14 |
| Patients seeking medical care |
– |
– |
– |
– |
6 |
4 |
4 |
4 |
5 |
13 |
11 |
5 (4–11) |
6.7 (3.7) |
– |
| Detectable SARS-COV-2 RNA duration by stratified condition | ||||||||||||||
| Patients detected through airport screening | 10 | 9 | 8 | – | – | – | – | – | – | – | – | 9 (8–10) | 9.0 (1.0) | 0.17 |
| Patients seeking medical care | – | – | – | – | 6 | 22 | 11 | 27 | 6 | 6 | 25 | 11 (6–25) | 14.7 (9.6) | – |
*COVID-19, coronavirus disease; NA, not applicable
†Patient 4 was asymptomatic throughout hospitalization and PCR results reflects days with detectable SARS-CoV-2 RNA following admission.
Page created: April 08, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.